Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongsheng Tu

Showing results (61-70 of 200) with videos related to

Pageof 20
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 25, 2025
Digital Profiling of Immune Biomarkers in Breast Cancer: Relation to Anthracycline BenefitElahe Shenasa, Ye He, Zehui Wang, et al.
Head & Neck|March 23, 2005
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositisGraeme G Duncan, Joel B Epstein, Dongsheng Tu, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 20, 2002
Ethics and industry-sponsored researchJoseph L Pater, Wendy Parulekar, Christopher O'Callagham, et al.
JMIR Research Protocols|June 10, 2017
Pain Improvement With Novel Combination Analgesic Regimens (PAIN-CARE): Randomized Controlled Trial ProtocolIan Gilron, Dongsheng Tu, Ronald Holden, et al.
Pain|August 11, 2020
Double-blind, randomized, placebo-controlled crossover trial of alpha-lipoic acid for the treatment of fibromyalgia pain: the IMPALA trialIan Gilron, Sylvia Robb, Dongsheng Tu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 2, 2022
Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials GroupLouis Everest, Scott Blommaert, Dongsheng Tu, et al.
Plos One|December 25, 2013
RSF1 and not cyclin D1 gene amplification may predict lack of benefit from adjuvant tamoxifen in high-risk pre-menopausal women in the MA.12 randomized clinical trialDana Keilty, Marguerite Buchanan, Katerina Ntapolias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2004
Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized studyAndrea Bezjak, Dongsheng Tu, Monica Bacon, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2016
Prognostic and predictive effects of diabetes, hypertension, and coronary artery disease among women on extended adjuvant letrozole: NCIC CTG MA.17Rachel A Goodwin, Rahima Jamal, Christopher M Booth, et al.
Gynecologic Oncology|August 14, 2013
Clinical and toxicity predictors of response and progression to temsirolimus in women with recurrent or metastatic endometrial cancerRachel A Goodwin, Rahima Jamal, Dongsheng Tu, et al.
Pageof 20

Showing results (61-70 of 200) with videos related to

Sort By:
Pageof 20
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 25, 2025
Digital Profiling of Immune Biomarkers in Breast Cancer: Relation to Anthracycline BenefitElahe Shenasa, Ye He, Zehui Wang, et al.
Head & Neck|March 23, 2005
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositisGraeme G Duncan, Joel B Epstein, Dongsheng Tu, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 20, 2002
Ethics and industry-sponsored researchJoseph L Pater, Wendy Parulekar, Christopher O'Callagham, et al.
JMIR Research Protocols|June 10, 2017
Pain Improvement With Novel Combination Analgesic Regimens (PAIN-CARE): Randomized Controlled Trial ProtocolIan Gilron, Dongsheng Tu, Ronald Holden, et al.
Pain|August 11, 2020
Double-blind, randomized, placebo-controlled crossover trial of alpha-lipoic acid for the treatment of fibromyalgia pain: the IMPALA trialIan Gilron, Sylvia Robb, Dongsheng Tu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 2, 2022
Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials GroupLouis Everest, Scott Blommaert, Dongsheng Tu, et al.
Plos One|December 25, 2013
RSF1 and not cyclin D1 gene amplification may predict lack of benefit from adjuvant tamoxifen in high-risk pre-menopausal women in the MA.12 randomized clinical trialDana Keilty, Marguerite Buchanan, Katerina Ntapolias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2004
Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized studyAndrea Bezjak, Dongsheng Tu, Monica Bacon, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2016
Prognostic and predictive effects of diabetes, hypertension, and coronary artery disease among women on extended adjuvant letrozole: NCIC CTG MA.17Rachel A Goodwin, Rahima Jamal, Christopher M Booth, et al.
Gynecologic Oncology|August 14, 2013
Clinical and toxicity predictors of response and progression to temsirolimus in women with recurrent or metastatic endometrial cancerRachel A Goodwin, Rahima Jamal, Dongsheng Tu, et al.
Pageof 20